To this end, HK2 has the potential to be a general marker for sensitively detecting sCTCs in different types of body fluids and across many cancer types, in combination with cytokeratin (CK, epithelial marker), CD45 (leukocyte marker) and DAPI (nucleus). This evidence concerns the gene PTPRC and cancer.